natgillin/translations-raw huggingface dataset:
This helps Briviact to stabilise electrical activity in the brain and prevent seizures.
To omogoča zdravilu Briviact, da stabilizira električno aktivnost v možganih in prepreči napade.
This helps prevent contamination and/or infection as well as entry of air into the insulin reservoir and leakage of insulin, which can cause inaccurate dosing.
To pomaga preprečiti onesnaženje in/ali okužbo, pa tudi vstopanje zraka v rezervoar z insulinom in iztekanje insulina, kar lahko povzroči nenatančno odmerjanje.
This helps the transplanted cells to ‘engraft’ (when they start to grow and produce normal blood cells).
To pomaga presajenim celicam, da se „primejo“ (začnejo rasti in proizvajati normalne krvne celice).
This helps to correct the iron overload and prevent damage to organs such as the heart or liver due to excess iron.
To pomaga odpravljati preobremenjenost z železom in preprečevati okvare organov, kot sta srce in ledvice, zaradi odvečnega železa.
This helps to enhance the results of tests that rely on measuring ultrasound, such as echocardiography and Doppler tests.
To pomaga izboljšati rezultate ultrazvočnih preiskav, kot so ehokardiografija in Dopplerjeve preiskave.
This helps to improve the signs and symptoms of Parkinson’s disease, such as stiffness and slowness of movement.
To pomaga pri izboljšanju znakov in simptomov Parkinsonove bolezni, kot sta otrplost mišic in upočasnjeno izvajanje gibov.
This helps to improve the symptoms of Parkinson’s disease, such as stiffness and slowness of movement.
To olajša simptome Parkinsonove bolezni, kot sta otrdelost mišic in upočasnjeno izvajanje gibov.
This helps to lower the blood pressure in the lungs and improve symptoms of CTEPH and PAH.
Na ta način pomaga znižati krvni tlak v pljučih in izboljša simptome CTEPH in PAH.
This helps to prevent asthma symptoms from occurring..
To pomaga preprečiti, da bi se pojavili simptomi astme.
This helps to protect against infection with the hepatitis B virus.
S tem zdravilo pomaga pri zaščiti pred okužbami z virusom hepatitisa B.
This helps to reduce deaths, signs of disease such as weight loss, and damage to lymphoid tissue associated with this infection.
S tem se zmanjšajo število poginov, znaki bolezni, kot je zmanjšanje telesne mase, in poškodbe limfnega tkiva, ki so povezane s to boleznijo.
This helps to reduce the amount of cholesterol in the blood.
To pomaga znižati količino holesterola v krvi.
This helps to reduce the amount of virus in the animal’s blood and lymphoid tissues and to reduce weight loss associated with PCV2 infection occurring during the fattening period.
S tem pomagamo zmanjšati količino virusov v krvi živali in njenih limfnih tkivih ter zmanjšati hujšanje pri okužbi s PCV2 v obdobju pitanja.
This helps to reduce the phosphate levels in the blood.
To znižuje raven fosfata v krvi.
This helps to reduce the pressure inside the eye.
Tako pomaga znižati očesni tlak.
This helps to stop IZBA getting into the rest of the body
Tako boste preprečili, da bi zdravilo IZBA prišlo v druge dele telesa.
This helps to stop TRAVATAN getting into the rest of the body
Tako boste preprečili, da bi TRAVATAN prišel v druge dele telesa.
This helps to stop your fits coming back or getting worse
Tako boste preprečili, da bi se epileptični napadi vrnili ali poslabšali.
This helps your body to get the full benefit from your medicine.
Na ta način bo vaše telo dobilo največ koristi od zdravila.
This herbal substance may stop Viramune from working properly.
To zeliišče lahko spremeni delovanje zdravila Viramune.
This high pressure can lead to glaucoma.
Visok očesni tlak lahko povzroči glavkom.
This HIV-1 mutation was observed in vitro and in HIV-1 infected patients.
Ta mutacija virusa HIV-1 je bila opažena in vitro in pri bolnikih, okuženih z virusom HIV-1.
This imbalance did not occur at one month: 2.0% versus 2.1% for ticagrelor patients with and without CHF history respectively; and 3.8% versus 1.4% with clopidogrel.
Te razlike po enem mesecu ni bilo: s ticagrelorjem 2,0 % med bolniki z anamnezo kongestivnega srčnega popuščanja in 2,1 % pri bolnikih brez takšne anamneze, s klopidogrelom pa 3,8 % v primerjavi z 1,4 %.
This immunity is passed onto the sow’s piglets through her colostrum.
Imunost se prek kolostruma prenaša s svinje na pujske.
This improvement was demonstrated even though 44% of patients in the placebo arm received ZYTIGA as subsequent therapy.
44% bolnikov iz kontrolne skupine (placebo) v nadaljevanju zdravljenja prejemalo zdravilo ZYTIGA.
This improves the effectiveness of interleukin-2, a medicine that stimulates the immune system to attack cancerous cells.
S tem se poveča učinkovitost interlevkina-2, zdravila, ki spodbuja imunski sistem k uničevanju rakavih celic.
This improves the symptoms of the disease.
To izboljša simptome bolezni.
This incidence of seizure, along with incidence of seizure in subjects receiving naltrexone / bupropion at the time of interim analysis in a large, ongoing cardiovascular outcomes trial, is no higher than the seizure rate with bupropion as a single agent at approved doses.
Ta pojavnost epileptičnih napadov, skupaj s pojavnostjo epileptičnih napadov pri preiskovancih, ki so prejemali naltrekson/bupropion v času vmesne analize v velikem še potekajočem preskušanju, v katerem preučujejo kardiovaskularne izide, ni večja kot pojavnost epileptičnih napadov pri uporabi bupropiona kot samostojnega zdravila z odobrenimi odmerki.
This include any possible side effects not listed in this leaflet.
Posvetujte se tudi, če opazite neželene učinke, ki niso navedeni v tem navodilu.
This included one study in 4,561 adults, which looked at the ability of Arepanrix H5N1 to trigger the production of antibodies (‘immunogenicity’) against this H5N1 strain, and one study comparing it with Pandemrix H5N1.
V eno študijo je bilo vključenih 4 561 odraslih, v kateri so proučevali sposobnost zdravila Arepanrix H5N1 za sprožitev tvorbe protiteles („imunogenost“) proti temu sevu H5N1, v drugi študiji pa so ga primerjali z zdravilom Pandemrix H5N1.
This included the vaccines that contain the same active substance as HBVaxPro.
To vključuje tudi cepiva, ki vsebujejo isto zdravilno učinkovino kot cepivo HBVaxPro.
This includes 250 patients treated with ofatumumab alone (in patients with relapsed or refractory CLL) and 261 patients treated in combination with an alkylating agent (in patients with previously untreated CLL who are inappropriate for a fludarabine-based therapy).
To vključuje 250 bolnikov, zdravljenih samo z ofatumumabom (pri bolnikih z recidivno ali refraktarno KLL), in 261 bolnikov, zdravljenih v kombinaciji z alkilirajočim zdravilom (pri bolnikih s predhodno nezdravljeno KLL, ki niso primerni za zdravljenje na podlagi fludarabina).
This includes 426 treatment-experienced patients and 360 treatment-naïve patients who received the recommended dose 300 mg twice daily and a further 588 treatment-experienced and treatment-naïve patients who received 300 mg once daily for at least 24 weeks.
To vključuje 426 že zdravljenih bolnikov in 360 še nezdravljenih bolnikov, ki so dobivali priporočeni odmerek 300 mg dvakrat na dan, ter dodatih 588 že zdravljenih bolnikov in še nezdravljenih bolnikov, ki so dobivali 300 mg enkrat na dan vsaj 24 tednov.
This includes 426 treatment-experienced patients and 360 treatment-naïve patients who received the recommended dose 300 mg twice daily and a further 588 treatment-experienced and treatment-naïve patients who received 300 mg once daily.
To vključuje 426 že zdravljenih bolnikov in 360 še nezdravljenih bolnikov, ki so dobivali priporočeni odmerek 300 mg dvakrat na dan, ter dodatih 588 že zdravljenih bolnikov in še nezdravljenih bolnikov, ki so dobivali 300 mg enkrat na dan vsaj 24 tednov.
This includes all adverse drug reactions which occurred during dabigatran therapy.
Zajeti so vsi neželeni učinki, ki so se pojavile med zdravljenjem z dabigatranom.
This includes all bleeding events, which occurred during dabigatran etexilate therapy.
Zajemajo vse krvavitve, ki so se pojavile med zdravljenjem z dabigatran eteksilatom.
This includes annual ultrasound to be performed after resumption of menstruation during off-treatment period.
To vključuje letni pregled z ultrazvokom po ponovnem pojavu menstruacije med obdobjem brez zdravljenja.
This includes any medicines without a prescription.
To vključuje tudi zdravila, ki ste jih dobili brez recepta.
This includes any other medicines obtained without a prescription, such as vitamins and herbal medicines.
To vključuje tudi zdravila, ki jih dobite brez zdravniškega recepta, kot so vitamini in zeliščna zdravila.
This includes any possible any side effects not listed in this leaflet.
Posvetujte se tudi, če opazite katere koli neželene učinike, ki niso navedeni v tem navodilu.
This includes any possible effects not listed in this leaflet.
Posvetujte se tudi, če opazite katere koli neželene učinke, ki niso navedeni v tem navodilu.
This includes any possible side effect not listed in the leaflet.
Posvetujte se tudi, če opazite katere koli neželene učinke, ki niso navedeni v tem navodilu.
This includes any possible side effect not listed in this leaflet.
Posvetujte se tudi, če opazite katerekoli neželene učinke, ki niso navedeni v tem navodilu.
This includes any possible side effect not listed in this leaflet.
Posvetujte se tudi, če opazite neželene učinke, ki niso navedeni v tem navodilu.
This includes any possible side effects not listed in the leaflet.
Posvetujte se tudi, če opazite katere koli neželene učinke, ki niso navedeni v tem navodilu.
This includes any possible side effects not listed in the leaflet.
Posvetujte se tudi, če opazite neželene učinke, ki niso navedeni v tem navodilu.
This includes any possible side effects not listed in this
Posvetujte se tudi, če opazite neželene učinke, ki niso navedeni v tem navodilu.
This includes any possible side effects not listed in this leafl et.
Posvetujte se tudi, če opazite neželene učinke, ki niso navedeni v tem navodilu.
This includes any possible side effects not listed in this leaflet
Posvetujte se tudi, če opazite katere koli neželene učinke, ki niso navedeni v tem navodilu.
This includes any possible side effects not listed in this leaflet,.
Posvetujte se tudi, če opazite katere koli neželene učinke, ki niso navedeni v tem navodilu.
This includes any possible side effects not listed in this leaflet.
Posvetujete se tudi, če opazite katerekoli neželene učinke, ki ni omenjen v tem navodilu.
This includes any possible side effects not listed in this leaflet.
Posvetujete se tudi, če opazite katerikoli neželeni učinek, ki ni omenjen v tem navodilu.
This includes any possible side effects not listed in this leaflet.
Posvetujte se tudi če opazite neželene učinke, ki niso navedeni v tem navodilu.
This includes any possible side effects not listed in this leaflet.
Posvetujte se tudi, če opazite katere koli neželene učineke, ki niso navedeni v tem navodilu.
This includes any possible side effects not listed in this leaflet.
Posvetujte se tudi, če opazite katere koli neželene učinke, ki niso navedeni tem navodilu.
This includes any possible side effects not listed in this leaflet.
Posvetujte se tudi, če opazite katere koli neželene učinke, ki niso naveeni v tem navodilu.
This includes any possible side effects not listed in this leaflet.
Posvetujte se tudi, če opazite kateri koli neželeni učinek, ki ni naveden v tem navodilu.
This includes any possible side effects not listed in this leaflet.
Posvetujte se tudi, če opazite katerikoli neželene učinke, ki niso omenjeni v tem navodilu in obvestite svojega zdravnika ali farmacevta.
This includes any possible side effects not listed in this leaflet.
Posvetujte se tudi, če opazite neželene učinke, ki niso navedene v tem navodilu.
This includes any possible side effects not listed in this leaflet.
Posvetujte se tudi, če opazite neželene učinke, ki niso navedeni v tem navodilu
This includes any possible side effects not listed in this leaflet.
Posvetujte se tudi, če opazite neželene učinke, ki niso navedeni v tem navodilu, obvestite svojega zdravnika ali farmacevta.
This includes any possible side effects not listed in this leaflet.
Posvetujte se tudi, če opazite neželene učinke, ki niso navedeni v tem navodilu. .
This includes any possible side effects not listed in this leaflet.
Posvetujte se tudi, če opazite neželene učinke, ki niso navedeni v tem navodilu.O neželenih učinkih lahko poročate tudi
This includes any possible side effects not listed in this leaflet.
Posvetujte se tudi, če opazite neželene učinke, ki niso navedni v tem navodilu.
This includes any possible side effects not listed in this leaflet.
Posvetujte se tudi, če opazite neželene učinke, ki niso v tem navodilu.
This includes any possible side effects not listed in this leaflet.
Posvetujte se tudi, če opazite neželene učinke, niso navedeni v tem navodilu.
This includes any possible side effects not listed in this leaflet.
Posvetujte se tudi, če opazite patere koli neželene učineke, ki niso navedeni v tem navodilu.
This includes any possible side effects not listed in this leaflet.
Posvetujte se tudi, če opazite učinke, ki niso navedeni v tem navodilu.
This includes any possible side effects not listed in this leaflet.
Posvetujte se tudi. če opazite katere koli neželene učinke, ki niso navedeni v tem navodilu.
This includes any possible side effects not listed in this leaflet.
Pred uporabo preberite priloženo navodilo
This includes any possible side effects not listed in this leaflet. .
Posvetujte se tudi, če opazite katere koli neželene učinke, ki niso navedeni v tem navodilu.
This includes any possible side effects not listed in this leaflet. .
Posvetujte se tudi, če opazite neželene učinke, ki niso navedeni v tem navodilu.
This includes any possible side effects not listed in this leaflet..
Posvetujte se tudi, če opazite neželene učinke, ki niso navedeni v tem navodilu.
This includes any possible side effects not listed in this leaflet.You can also report side effects directly via the national reporting system listed in Appendix V*.
Posvetujte se tudi, če opazite neželene učinke, ki niso navedeni v tem navodilu.
This includes any possible side effects not listed in this leaftlet.
Posvetujte se tudi, če opazite katere koli neželene učinke, ki niso navedeni v tem navodilu.
This includes any possible side- effects not listed in this leaflet.
Posvetujte se tudi, če opazite katere koli neželene učinke, ki niso navedeni v tem navodilu.
This includes any possible side-effects not listed in this leaflet.
Posvetujte se tudi, če opazite katere koli neželene učinke, ki niso navedeni v tem navodilu.
This includes any side effects not listed in this leaflet.
Posvetujte se tudi, če opazite katere koli neželene učinek, ki niso navedeni v tem navodilu.
This includes avoiding storage at temperatures exceeding 30°C, and not exceeding a 28 day period where the average storage temperature for the product is below 25°C (but above 2°C - 8°C).
To vključuje izogibanje shranjevanju pri temperaturi nad 30 °C, obdobje shranjevanja, med katerim je povprečna temperatura pod 25 °C (vendar nad 2 °C – 8 °C), pa ne sme biti daljše od 28 dni.
This includes certain medicines used to:
To vključuje določena zdravila za:
This includes co-administration with medicinal products that reduce dolutegravir exposure (e.g. magnesium/ aluminium-containing antacid, iron and calcium supplements, multivitamins and inducing agents, etravirine (without boosted protease inhibitors), tipranavir/ritonavir, rifampicin, St. John’s wort and certain anti- epileptic drugs) (see section 4.5).
To vključuje sočasno jemanje z zdravili, ki zmanjšujejo izpostavljenost dolutegravirju (npr. antacidna zdravila, ki vsebujejo magnezij/aluminij, železovi ali kalcijevi dodatki, multivitaminski pripravki in spodbujevalci, etravirin (brez okrepljenih zaviralcev proteaz), tipranavir/ritonavir, rifampicin, šentjanževka in določena zdravila proti epilepsiji (glejte poglavje 4.5).
This includes data from two placebo-controlled studies, three open-label studies, three compassionate-use subjects and postmarketing reports.
Zajeti so podatki iz dveh študij, kontroliranih s placebom, treh odprtih študij, treh bolnikov, ki so prejeli zdravilo za dobrodelno uporabo, in poročil po začetku trženja.
This includes herbal medicines and other medicines bought without a prescription.
To velja tudi za zdravila rastlinskega izvora in druga zdravila, ki se dobijo brez recepta.
This includes in particular:
To velja še posebno za:
This includes in particular: other iron chelators, which must not be taken with EXJADE, antatacids (medicines used to treat heartburn) containing aluminium, which should not be taken at the same time of day as EXJADE,
To vključuje še posebno: druge kelatorje železa, ki se jih ne sme jemati sočasno z zdravilom EXJADE, antacide (zdravila za lajšanje težav pri zgagi), ki vsebujejo aluminij in se jih ne sme jemati istočasno kot zdravilo EXJADE,
This includes information on storage procedures, since incorrect storage after reconstitution can cause increased levels of activated NovoThirteen, thereby increasing the risk of thrombosis (formation of blood clots in the blood vessels), and information on administration procedures, since the factor XIII concentration in NovoThirteen is different from other factor XIII- containing medicines.
Vsebovale bodo informacije o postopkih shranjevanja, saj lahko nepravilno shranjevanje po pripravi povzroči povišane ravni aktiviranega zdravila NovoThirteen in s tem poveča tveganje za trombozo (tvorjenje krvnih strdkov v ožilju), ter informacije o načinih uporabe, saj je koncentracija faktorja XIII v zdravilu NovoThirteen drugačna kot pri drugih zdravilih, ki ga vsebujejo.
This includes medicines for irregular heart rhythm (such as digoxin), for treating high blood pressure (such as enalapril maleate), anti-seizure medicines (such as valproic acid, phenytoin, carbamazepine, lamotrigine, oxcarbazepine, topiramate, gabapentin, vigabatrin, zonisamide and levetiracetam), levothyroxine (used to treat thyroid hormone deficiency), oral birth control medicines (oestrogen, progestogen or combination pills), immune system suppressing medicines (such as cyclosporine, mycophenolate mofetil, tacrolimus).
To vključuje zdravila za neenakomerno bitje srca (kot na primer digoxin), zdravila za zdravljenje visokega krvnega tlaka (kot je nap primer enalpril maleat), zdravila proti epileptičnim napadom (kot so valproična kislina, fenitoin, karbamazepin, lamotrigin, oksacarbazepin, topiramat, gabapentin, vigabatrin, zonisamid in levetiracetam), levotiroksin (ki se uporablja za zdravljenje pomanjkanja ščitničnega hormona) in peroralna kontracepcijska zdravila (estrogen, progestogen ali kombinirane tabletke), zdravila za zaviranje imunskega sistema (kot je ciklosporin, mikofenolat mofetil, takrolimus).
This includes medicines obtained without a prescription and herbal medicines.
To velja tudi za pripravke rastlinskega izvora.
This includes medicines obtained without a prescription and herbal medicines.
To velja tudi za zdravila, ki ste jih dobili brez recepta in za zdravila rastlinskega izvora.
This includes medicines obtained without a prescription including herbal medicines.
To vključuje zdravila brez recepta, vključno z zdravili rastlinskega izvora.
This includes medicines obtained without a prescription or if they have recently received any other vaccine.
To velja tudi za zdravila, prejeta brez recepta.
This includes medicines that you can get without a prescription.
To velja tudi za zdravila, ki jih lahko dobite brez recepta.
This includes medicines without a prescription and herbal medicines.
To vključuje tudi zdravila, ki ste jih dobili brez recepta, in zdravila rastlinskega izvora.
This includes medicines you get without a prescription or herbal medicines.
Sem sodijo tudi zeliščni pripravki.
This includes monitoring of serum concentrations of tobramycin.
Take bolnike je terba ustrezno klinično spremljati, kar vključuje spremljanje koncentracije tobramicina v serumu.
This includes multiple sclerosis, Guillain-Barre syndrome, if you have fits or have been diagnosed with ‘optic neuritis’.
Težave kot so multipla skleroza, Guillain-Barre sindrom, če ste imeli izpade ali so vam diagnosticirali optični nevritis.
This includes multiple sclerosis, Guillain-Barre syndrome, if you have fits or have been diagnosed with ‘optic neuritis’.
To vključuje bolezni, kot so multipla skleroza, Guillain-Barréjev sindrom, če ste imeli napade krčev ali so vam diagnosticirali "optični nevritis".
This includes multiple sclerosis, Guillain-Barre syndrome, if you have fits or have been diagnosed with ‘optic neuritis’.
To vključuje bolezni, kot so multipla skleroza, Guillain-Barréjev sindrom, če ste imeli napade krčev ali so vam diagnosticirali optični nevritis.
This includes patients who are having myocardial infarction (a heart attack) with ‘ST segment elevation’ (an abnormal reading on the electrocardiogram or ECG).
To vključuje tudi bolnike, ki so imeli miokardni infarkt (srčni napad) z dvigom spojnice ST (nenormalnim zapisom na elektrokardiogramu ali EKG).
This includes sedatives (such as anxiolytics, hypnotics, antipsychotics, H1 anti-histamines, opiate derivatives and barbiturates).
To vključuje pomirjevala (kot so anksiolitiki, hipnotiki, antipsihotiki, antihistaminiki H1, derivati opiatov in barbiturati);
This includes small- and medium-sized breeds up to and including eight months of age, large breeds up to one year of age and giant breeds up to 18 months of age.
To vključuje majhne in srednje velike pasme do konca osmega meseca starosti, velike pasme do enega leta starosti in
This includes some cases of inflammation of the liver (hepatitis), which can be sudden and intense (fulminant hepatitis), and liver failure, which can be both fatal.
Med njimi nekaj primerov vnetja jeter (hepatitisa), ki je lahko nenadno (fulminantni hepatitis), in jetrne odpovedi, ki so lahko oba končata s smrtjo.
This includes spontaneous case reports as well as serious adverse events from ongoing studies, the expanded access program, clinical pharmacology studies and exploratory studies in unapproved indications.
To vključuje tako spontano sporočene primere kot tudi resne neželene učinke iz študij v teku, iz programov razširjene uporabe, študij klinične farmakologije in raziskovalnih študij neodobrenih indikacij.
This includes spontaneous case reports as well as serious adverse events from ongoing studies, the expanded access programs, clinical pharmacology studies and exploratory studies in unapproved indications.
To vključuje tako spontano sporočene primere kot tudi resne neželene učinke iz študij v teku, iz programov razširjene uporabe, študij klinične farmakologije in raziskovalnih študij neodobrenih indikacij.
This includes studies with immunosuppressive drugs.
To vključuje študije z imunosupresivnimi zdravili.
This includes the signs and symptoms you need to look out for (fever or infection, bruising or bleeding).
To vključuje tudi znake in simptome, na katere morate biti pozorni (vročino ali okužbo, podplutbe ali krvavitev).
This includes: antacids (such as aluminium/magnesium hydroxide or calcium carbonate).
Ta zdravila vključujejo: antacide (kot so aluminijev/magnezijev hidroksid ali kalcijev karbonat).
This includes: eating a balanced diet rich in calcium and vitamin D
To vključuje uravnoteženo prehrano, bogato s kalcijem in vitaminom D,
This includes: eating a balanced diet rich in calcium and vitamin D
To vključuje: uravnoteženo prehrano, bogato s kalcijem in vitaminom D,
This includes: eating a balanced diet rich in calcium and vitamin D,
To vključuje: uravnoteženo prehrano, bogato s kalcijem in vitaminom D,
This includes: medicines known to reduce the activity of an enzyme called ‘CYP1A2’.
To vključuje: zdravila, ki dokazano zmanjšujejo aktivnost encima, imenovanega „CYP1A2“.
This includesany possible side effects not listed in this leaflet.
Posvetujte se tudi, če opazite neželene učinke, ki niso navedeni v tem navodilu.
This incompatibility has to be considered during the preparation and administration of Torisel.
To inkompatibilnost moramo upoštevati pri pripravi in uporabi zdravila Torisel.